Access to quality essential medicines in the developing world

• In: A4 - Do patents limit access to new medicines? on Tuesday, 2 September 2014, 12:15-13:45
• At: Bangkok (Thailand) (2014)
• Type: Presentation
• By: HOLLOWAY, Kathleen (World Health Organisation, Regional Office for South-East Asia, Essential Drugs and Other Medicines, New delhi, India)
• Abstract:

  Access to essential medicines is core to universal health coverage. Government expenditure on health, pharmaceuticals and the infrastructure to manage pharmaceuticals is very low, while out-of-pocket expenditure is very high, in many Asian countries compared to high income countries. In addition there are inefficiencies in the health system

  ..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login